Skip to main content
V

VIVOZON PHARMACEUTICAL CO., LTD. — Investor Relations & Filings

Ticker · 082800 ISIN · KR7082800004 KO Manufacturing
Open in API
Filings indexed 587 across all filing types
Latest filing 2026-04-30 Regulatory Filings
Country KR South Korea
Listing KO 082800

About VIVOZON PHARMACEUTICAL CO., LTD.

https://www.vivozon.com/

VIVOZON PHARMACEUTICAL CO., LTD. is a research and development company specializing in the discovery and commercialization of innovative drugs, with a primary focus on pain and central nervous system (CNS) diseases. The company utilizes a multi-target drug development platform to create new chemical entities that act on multiple targets to achieve synergistic efficacy. This approach integrates efficacy-based screening from the early stages of discovery to identify candidate substances with a high potential for successful clinical development. Its lead pipeline candidate is Opiranserin (VVZ-149), a first-in-class, non-narcotic injectable analgesic for post-operative pain management. The company is actively expanding its pipeline to address a broader range of unmet medical needs within the CNS field.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득 (제15회차)
Regulatory Filings
2026-04-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing an executive’s acquisition/disposition of company shares with specific dates, quantities, and insider details. This matches an insider trading report by a director or officer. Therefore, it falls under Director’s Dealing (DIRS).
2026-04-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서,” which discloses an officer’s and major shareholder’s specific securities holdings, percentage ownership, and detailed acquisition/disposal transactions. This matches an insider transaction report by directors/executives. Therefore, it is classified as a Director’s Dealing filing.
2026-04-15 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 1% confidence The document is titled “자기주식처분결과보고서” (Report on disposal of treasury stock) filed to the Financial Supervisory Service and provides detailed data on the sale/disposal of the company’s own shares (dates, share counts, prices, post‐disposal holdings). This clearly corresponds to a Transaction in Own Shares report.
2026-04-15 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 1% confidence The document is a Major Event Report (‘주요사항보고서’) concerning the company’s decision to dispose of treasury shares (self-owned stock), detailing quantities, disposal methods, purposes, and related party information. This corresponds exactly to a transaction involving the company’s own shares. Under the provided taxonomy, a report on share repurchase or disposal by the company falls under “Transaction in Own Shares” (Code: POS).
2026-04-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a detailed “주식등의 대량보유상황보고서” (Large Shareholding Status Report) filed under Korea’s Capital Markets Act, containing precise disclosures of shareholdings, percentages, changes in ownership and related contracts. It is a regulatory notification of changes in significant share ownership levels by major shareholders, fitting the ‘Major Shareholding Notification’ definition. Therefore, it should be classified under code MRQ.
2026-04-09 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.